Top Markets
#1 Purr Purr +59.29%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +32.91%
#4 Kinetiq Kinetiq +30.53%
#5 ApeX ApeX +25.45%
#6 Non-Playable Coin Non-Playable Coin +21.19%
#7 OriginTrail OriginTrail +19.37%
#8 Morpho Morpho +18.34%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.17%
#10 Fake World Assets Fake World Assets +18.14%
Coin of the day
Purr Purr
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
ArcticZymes Technologies ASA ArcticZymes Technologies ASA

ArcticZymes Technologies ASA

AZT
Clasificación en acciones #21263
ArcticZymes Technologies ASA is a leading life sciences firm dedicated to the... ArcticZymes Technologies ASA is a leading life sciences firm dedicated to the development, production, and global sale of recombinant enzymes. These specialized enzymes are essential for a variety of applications, including molecular research, in vitro diagnostic testing, and processes within biomanufacturing. The company's diverse product lineup includes several key enzymatic solutions. For example, its salt active nuclease is instrumental in eliminating nucleic acids during the manufacturing of viral vectors, recombinant proteins, and other critical reagents. ArcticZymes also supplies shrimp alkaline phosphatase and accompanying kits, which are vital for purifying samples before both Sanger and next-generation sequencing. Another significant product is cod UNG, frequently utilized in viral and other molecular diagnostic assays, alongside double-strand specific DNases and their related kits, engineered for the efficient removal of double-stranded DNA. The firm's polymerases are designed to drive technological progress in life science, molecular diagnostics, NGS, and synthetic biology. Furthermore, it offers proteinase for applications in microbiological diagnostics and liquid biopsies, and ligases, which are crucial for connecting DNA and RNA fragments. ArcticZymes Technologies boasts a broad international presence, serving markets in Norway, Germany, Lithuania, Italy, various other European nations, the United States, and additional global territories. Founded in 1990, the enterprise was initially known as Biotec Pharmacon ASA until June 2020, when it officially rebranded to its current name. Its corporate headquarters are located in Tromsø, Norway.
Precio por acción
$2.18
Última sincronización: 2026-08-21
Capitalización bursátil
$111.34M
Cambio (1 día)
-4.15%
Cambio (1 año)
-25.43%
País
NO
Comercio ArcticZymes Technologies ASA (AZT)

Categoría

Healthcare
Historial del precio de la acción de ArcticZymes Technologies ASA (AZT)
Precio más alto de cierre: $2.12 el 2026-08-01

Precio más bajo de cierre: $3.35 el 2005-11-01
Historial del precio de la acción de ArcticZymes Technologies ASA desde 2005 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 11.22%
2025 71.95%
2024 -68.25%
2023 -48.23%
2022 -26.04%
2021 31.80%
2020 1,325.02%
2019 15.03%
2018 -45.48%
2017 -37.45%
2016 -6.08%
2015 -38.71%
2014 42.43%
2013 76.63%
2012 12.34%
2011 -28.59%
2010 56.84%
2009 -53.59%
2008 -71.04%
2007 -19.18%
2006 112.31%
2005 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH